$177.22
+2.29 (+1.31%)
AZN News30 articles
Novo Nordisk Shares Rally as Healthcare Sector Lifts OMXC25
Novo Nordisk B shares rose 5% to 294.4 Danish crowns, leading the OMXC25 higher as healthcare stocks gained. The rally came amid a cyber incident and ongoing competition with Eli Lilly in oral obesity drugs.
G7 Leaders Debate AI Model Access Amid OpenAI's $1T IPO Plan and Rising China Competition
G7 leaders debate AI model access as OpenAI files for a $1T IPO. Anthropic restricts models, China boosts local AI, and cybersecurity deals surge.
GSK Acquires Nuvalent for $10.6B in Oncology Push Ahead of HIV Patent Cliff
GSK buys Nuvalent for $10.6B, paying a 40% premium, to strengthen its oncology portfolio and offset upcoming HIV drug patent losses.
Novo Nordisk Shares Slide 4% Despite Wegovy Pill Prescriptions Surpassing 3 Million
Novo Nordisk shares dropped over 4% despite the Wegovy pill hitting 3 million U.S. prescriptions, as investors weighed profit margins against fierce competition from Eli Lilly and AstraZeneca.
Merck Shares Jump as New Drug Data Eases Keytruda Concerns
Merck shares surged 4.9% to $120.26 after ASCO data showed its new cancer drug sac-TMT combined with Keytruda improved progression-free survival, reinforcing confidence in the post-Keytruda pipeline.
Abivax shares drop despite positive Phase 3 results for ulcerative colitis drug
Abivax shares plunged 33.7% after hours despite obefazimod achieving clinical remission in over 50% of patients in a Phase 3 trial. The company plans to submit an FDA application in late Q4 2026.
AIM ImmunoTech Surges on Early Pancreatic Cancer Trial Enrollment Completion
AIM ImmunoTech shares surged over 100% after its Phase 2 pancreatic cancer trial reached final enrollment ahead of schedule, with the primary endpoint readout set for December 2026.
FTSE 100 Drops as Oil Surge on Iran Tensions Ends Winning Streak
London's FTSE 100 dropped 0.97% at the open Thursday, ending an eight-session winning streak as Brent crude jumped 3.6% on renewed U.S.-Iran tensions, triggering a broad risk-off move.
Hormuz Crisis Looms Over Oil Markets as Physical Prices Surge
Brent crude slipped to $108.17 on Friday after Iran proposed talks, but the Strait of Hormuz remains disrupted, and physical crude grades trade near $130, signaling further price spikes ahead.
FTSE 100 Slides as Healthcare Stocks Weigh Despite Earnings Beats
The FTSE 100 slipped 0.6% as healthcare giants AstraZeneca and GSK declined despite topping profit forecasts, while Lloyds Banking Group's profit jump failed to lift sentiment.
Meta's Q1 Earnings to Gauge AI Investment Payoff Amid Rising Costs
Meta Platforms will announce first-quarter financial results on April 29, as investors assess whether advertising gains can sustain the company's aggressive artificial intelligence investments.
Pfizer Gains on FDA Priority Review for Padcev as Pipeline Pivots Post-COVID
Pfizer shares advanced after the FDA granted priority review for its Padcev bladder cancer therapy, setting an August decision. Investors await Q1 results to gauge progress in oncology and obesity drugs against fading COVID sales.
Cocoa Prices Plunge on European Demand Slump, Asian Markets Mixed
Cocoa prices tumbled over 3% after weak European demand data, while Asian markets diverged with Hong Kong falling and India's Sensex gaining.
Markets Rally on Geopolitical Hopes; AI and Growth ETFs Advised for Young Investors
Equities advanced on optimism for a resolution to the Iran conflict, while a market veteran recommends young investors allocate monthly funds to Vanguard's VGT and VUG ETFs for long-term growth.
Intel Buys Back $14.2B Stake in Irish Fab, Bolstering AI Strategy Ahead of Earnings
Intel has regained full ownership of its Fab 34 facility in Ireland through a $14.2 billion buyback of Apollo's stake. The move strengthens Intel's manufacturing control as it prepares to report quarterly results and advance its AI initiatives.
Pfizer Shares Reach New Peak Amid Divergent Views on Future Growth
Pfizer shares surged to a 52-week high of $28.30, driven by robust quarterly results and promising oncology data. Analysts remain divided on whether the stock's rally is sustainable given looming growth challenges.
IBM's AI Strategy Under Scrutiny as Q1 Report Looms Amid Stock Slump
IBM shares are trading nearly 27% below their 52-week peak, with pressure mounting on its AI strategy ahead of first-quarter results on April 22. The company recently completed its $11 billion acquisition of Confluent.
AST SpaceMobile Targets April 10 for BlueBird 7 Launch Amid Rival Rocket Lab's ESA Milestone
AST SpaceMobile has scheduled its BlueBird 7 satellite launch for April 10, while Rocket Lab successfully completed its first dedicated mission for the European Space Agency. Both companies are advancing amid a backdrop of robust financial results and industry momentum.
FTSE 100 Flat Amid Consumer Weakness, AstraZeneca Gains
The FTSE 100 was little changed, up just 0.1%, as disappointing UK economic data weighed on sentiment. AstraZeneca shares rose on positive trial results.
Indian Markets Rebound Sharply on Easing Oil Prices and IT Rally
Indian equity indices staged a strong recovery on March 20, 2026, with the Sensex jumping 891 points. The rally was fueled by falling crude oil prices and a surge in IT stocks.
Eli Lilly's Retatrutide Hits Phase 3 Goals, Stock Pressured by Pricing Concerns
Eli Lilly announced its experimental drug retatrutide achieved primary goals in a Phase 3 trial, significantly reducing blood sugar and weight. The stock declined 1.3% to $918.05 amid an HSBC downgrade and ongoing concerns over drug pricing in the U.S. market.
Markets Mixed as Bitcoin Soars, Texas Emerges as Financial Hub
Global markets showed divergent trends with Bitcoin climbing above $75,000 as a digital safe haven, while Indian equities recovered strongly. Texas solidified its position as a major financial center with new exchange launches.
Palantir Shares Decline Despite AI Partnership Announcements
Palantir Technologies shares dropped 2.7% on Friday, underperforming broader markets, following announcements of new artificial intelligence and defense partnerships. The stock remains down nearly 14% for 2026 despite significant gains over the past year.
Iran Conflict Fuels Global Inflation Surge as Oil Tops $100
The Iran conflict has triggered a severe oil supply disruption, pushing Brent crude above $100 a barrel and sending shockwaves through global freight, agriculture, and consumer markets.
India Races to Secure LPG Amid Gulf War Disruption, Sparks Induction Stove Rush
India has invoked emergency powers to redirect LPG supplies from commercial to residential users following Gulf war disruptions, causing restaurants to limit hot meals and triggering a massive spike in induction cooker purchases.
FTSE 100 Retreats on Oil Spike, Rate Cut Hopes Dim
London's FTSE 100 declined 0.7% in early Thursday trading as Brent crude surged past $100 a barrel, dampening expectations for near-term Bank of England rate cuts and pressuring consumer-focused sectors.
FTSE 100 Rallies on Oil Retreat, Persimmon Surges
London's FTSE 100 rebounded 1.6% to 10,412.54, snapping a three-day losing streak as oil prices retreated. Persimmon shares surged after the homebuilder issued optimistic full-year guidance.
NVIDIA, ABB Forge Factory AI Alliance to Bridge Simulation-Reality Gap
NVIDIA and ABB have announced a strategic partnership to embed NVIDIA's Omniverse platform into ABB's RobotStudio software, aiming to achieve near-perfect accuracy when transferring robot training from simulation to physical factories. The collaboration is a key move for NVIDIA to expand its industrial AI footprint beyond data centers.
Middle East Conflict Sparks Historic Oil Price Surge, Strains Global Supply
Oil prices surged dramatically on Monday, with Brent crude briefly exceeding $119 per barrel, following supply disruptions in the Middle East linked to regional conflict. Governments and companies scrambled to respond to the market shock.
FTSE 100 Plunges on Oil Price Surge and Geopolitical Tensions
London's FTSE 100 index opened sharply lower, dropping 1.75%, as a surge in crude oil prices above $119 per barrel rattled markets. The spike, driven by Middle East supply concerns, particularly punished airline and mining shares.